Purification and characterization of actin from normal and chronic lymphocytic leukemia lymphocytes

• Published in: Cancer research (Chicago, Ill.) Vol. 43; no. 10; pp. 4966 - 4973
• Main Authors: LIEBES, L. F, STARK, R, NEVRLA, D, GRUSKY, G, ZUCKER-FRANKLIN, D, SILBER, R
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Association for Cancer Research 01.10.1983
• Subjects: actin; Actins - blood; Biological and medical sciences; Chromatography, High Pressure Liquid; chronic lymphatic leukemia; Hematologic and hematopoietic diseases; Humans; Isoelectric Focusing; Leukemia, Lymphoid - analysis; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; lymphatic leukemia (chronic); lymphocytes; Lymphocytes - analysis; man; Medical sciences; Microscopy, Electron; Myosin Subfragments - analysis; Myosins - analysis; Peptide Fragments - analysis; Chronic lymphocytic leukemia; Electron microscopy; Lymphocyte; ATPase
• ISSN: 0008-5472; 1538-7445

Previous studies from this laboratory have shown actin to be a major protein of human lymphocytes (Stark, R., Liebes, L. F., Nevrla, D., and Silber, R. Biochem. Med., 27: 200-206, 1982). We now report the purification to homogeneity and characterization of actin from blood lymphocytes of normal subjects and patients with chronic lymphocytic leukemia. The recovery of the purified protein was about 20%. The properties of the lymphocyte actins were compared to each other and to those of rabbit skeletal muscle actin. Lymphocyte actin consisted of beta and gamma forms in a 2:1 ratio. The Mr 42,000 was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Normal and leukemic lymphocyte actin had similar polymerization properties as assessed by viscosity measurements at 25 degrees and 4 degrees, and the ultrastructural appearance of the filaments was the same. Similar patterns were observed between normal and chronic lymphocytic leukemia actin tryptic digests analyzed by high-performance liquid chromatography. The Vmax of the actin-activated myosin Mg2+ ATPase activity was compared using rabbit skeletal muscle heavy meromyosin and subfragment 1 preparations. The values obtained with rabbit skeletal muscle and normal lymphocyte actin were identical. The Vmax observed with chronic lymphocytic leukemia lymphocyte actin was 70% of that obtained with normal lymphocyte actin. The amount of actin needed to produce half-maximal activation (Kapparent) of heavy meromyosin and subfragment 1 were, respectively, 26 and 25 microM for normal lymphocytes and 18 and 24 microM for chronic lymphocytic leukemia lymphocytes. The anomalous ATP activation by actin did not reflect differences in B-:T-cell subpopulations between chronic lymphocytic leukemia and normal lymphocytes. The possible significance of the observed differences between the myosin Mg2+ ATPase activation by chronic lymphocytic leukemia and normal lymphocyte actin is discussed.